Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study.
Silverman SL, Chines AA, Kendler DL, Kung AW, Teglbjærg CS, Felsenberg D, Mairon N, Constantine GD, Adachi JD; Bazedoxifene Study Group. Silverman SL, et al. Among authors: chines aa. Osteoporos Int. 2012 Jan;23(1):351-63. doi: 10.1007/s00198-011-1691-1. Epub 2011 Jul 21. Osteoporos Int. 2012. PMID: 21779819 Clinical Trial.
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial.
Silverman SL, Christiansen C, Genant HK, Vukicevic S, Zanchetta JR, de Villiers TJ, Constantine GD, Chines AA. Silverman SL, et al. Among authors: chines aa. J Bone Miner Res. 2008 Dec;23(12):1923-34. doi: 10.1359/jbmr.080710. J Bone Miner Res. 2008. PMID: 18665787 Free article. Clinical Trial.
Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis.
Christiansen C, Chesnut CH 3rd, Adachi JD, Brown JP, Fernandes CE, Kung AW, Palacios S, Levine AB, Chines AA, Constantine GD. Christiansen C, et al. Among authors: chines aa. BMC Musculoskelet Disord. 2010 Jun 22;11:130. doi: 10.1186/1471-2474-11-130. BMC Musculoskelet Disord. 2010. PMID: 20569451 Free PMC article. Clinical Trial.
A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture.
Palacios S, Silverman SL, de Villiers TJ, Levine AB, Goemaere S, Brown JP, De Cicco Nardone F, Williams R, Hines TL, Mirkin S, Chines AA; Bazedoxifene Study Group. Palacios S, et al. Among authors: chines aa. Menopause. 2015 Aug;22(8):806-13. doi: 10.1097/GME.0000000000000419. Menopause. 2015. PMID: 25668306 Clinical Trial.
An evaluation of the Fracture Risk Assessment Tool (FRAX®) as an indicator of treatment efficacy: the effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX®.
Kaufman JM, Palacios S, Silverman S, Sutradhar S, Chines A. Kaufman JM, et al. Osteoporos Int. 2013 Oct;24(10):2561-9. doi: 10.1007/s00198-013-2341-6. Epub 2013 Apr 18. Osteoporos Int. 2013. PMID: 23595562 Clinical Trial.
Efficacy and safety of bazedoxifene in postmenopausal Asian women.
Xu L, Tsai KS, Kim GS, Wu Y, Vincendon P, Chines AA, Constantine GD. Xu L, et al. Among authors: chines aa. Osteoporos Int. 2011 Feb;22(2):559-65. doi: 10.1007/s00198-010-1259-5. Epub 2010 Jun 10. Osteoporos Int. 2011. PMID: 20535607 Clinical Trial.
Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study.
Miller PD, Chines AA, Christiansen C, Hoeck HC, Kendler DL, Lewiecki EM, Woodson G, Levine AB, Constantine G, Delmas PD. Miller PD, et al. Among authors: chines aa. J Bone Miner Res. 2008 Apr;23(4):525-35. doi: 10.1359/jbmr.071206. J Bone Miner Res. 2008. PMID: 18072873 Free article. Clinical Trial.
88 results